Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-26 @ 1:30 AM
NCT ID:
NCT01986933
Group ID:
EG006
Title:
Nemoliozumab (0.5 mg/kg) Q4W (Part A + Part B)
Description:
Data from Part A, Part B and Safety Follow-up period were analyzed.
Placebo-controlled period (Part A) (Day 1 to Week 12):
Patients randomized to this group received Nemoliozumab (0.5 mg/kg) subcutaneously every 4 weeks on Day 1, Week 4 and Week 8.
Active-to-active period (Part B) (up to Week 64):
Patients in the Nemoliozumab (0.5 mg/kg) Q4W group during Part A continuously used the same regimen of Nemoliozumab in Part B.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
54
Other Number Affected:
35
Other Number At Risk:
54
Study:
NCT01986933
Results Section:
NCT01986933
Adverse Events Module:
NCT01986933